FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 217 filers reported holding FIBROGEN INC in Q4 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $226,000 | -51.7% | 6,513 | -48.4% | 0.01% | -61.9% |
| Q4 2020 | $468,000 | -29.5% | 12,613 | -21.9% | 0.02% | -38.2% |
| Q3 2020 | $664,000 | +24.6% | 16,143 | +22.8% | 0.03% | +13.3% |
| Q2 2020 | $533,000 | +16.6% | 13,143 | 0.0% | 0.03% | -9.1% |
| Q1 2020 | $457,000 | +5.1% | 13,143 | +29.6% | 0.03% | +32.0% |
| Q4 2019 | $435,000 | +30.6% | 10,143 | +12.7% | 0.02% | +25.0% |
| Q3 2019 | $333,000 | -47.4% | 9,000 | -35.7% | 0.02% | -48.7% |
| Q2 2019 | $633,000 | +45.5% | 14,000 | +75.0% | 0.04% | +44.4% |
| Q1 2019 | $435,000 | +17.6% | 8,000 | 0.0% | 0.03% | +8.0% |
| Q4 2018 | $370,000 | -23.9% | 8,000 | 0.0% | 0.02% | -10.7% |
| Q3 2018 | $486,000 | -3.0% | 8,000 | 0.0% | 0.03% | -6.7% |
| Q2 2018 | $501,000 | +8.4% | 8,000 | -20.0% | 0.03% | +3.4% |
| Q1 2018 | $462,000 | -18.8% | 10,000 | -16.7% | 0.03% | -19.4% |
| Q4 2017 | $569,000 | – | 12,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |